-
Je něco špatně v tomto záznamu ?
Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma
WG. McCluggage, H. Vosmikova, J. Laco,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu kazuistiky, časopisecké články
- MeSH
- adenokarcinom diagnostické zobrazování genetika patologie MeSH
- ductus Mülleri patologie MeSH
- imunohistochemie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mutace MeSH
- nádory vaječníků diagnostické zobrazování genetika patologie MeSH
- protoonkogenní proteiny p21(ras) genetika MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- serózní cystadenokarcinom diagnostické zobrazování genetika patologie MeSH
- ultrasonografie MeSH
- vagina diagnostické zobrazování MeSH
- Wolffovy vývody patologie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
Mesonephric-like adenocarcinomas are rare neoplasms occurring in the uterine corpus and ovary which bear a close morphologic resemblance to cervical mesonephric adenocarcinomas. They also have a similar immunophenotype and harbor similar molecular abnormalities to mesonephric adenocarcinomas and it is debated whether they are truly of mesonephric origin or represent Mullerian neoplasms closely mimicking mesonephric adenocarcinomas. We report an unusual case with bilateral ovarian serous borderline tumors and extraovarian low-grade serous carcinoma (invasive implants). In one ovary, there was a component of mesonephric-like adenocarcinoma. The immunophenotypes of the serous and the mesonephric-like components were distinct and as expected for the individual tumor types (serous component diffusely positive with WT1 and estrogen receptor and negative with GATA3, TTF1 and CD10; mesonephric-like component WT1 and estrogen receptor negative and GATA3, TTF1, and CD10 positive; both components diffusely positive with PAX8 and exhibiting "wild-type" p53 immunoreactivity). In all components (bilateral serous borderline tumors, low-grade serous carcinoma and mesonephric-like adenocarcinoma), an identical KRAS mutation was detected (NM_004985.4): c.35G>A, p.(G12D) proving a clonal association between the serous and mesonephric-like components and excluding a collision neoplasm. This represents the second reported case of a combined ovarian low-grade serous tumor and mesonephric-like adenocarcinoma; in the previously reported case, an identical NRAS mutation was present in both components. These 2 cases provide evidence that ovarian mesonephric-like adenocarcinomas have, at least in some cases, a Mullerian origin and differentiate along mesonephric lines. We present additional evidence for this by reviewing associated findings in published and unpublished ovarian mesonephric-like adenocarcinomas; 8 of 11 of these neoplasms contained other Mullerian lesions in the same ovary, mainly endometriosis and adenomas/adenofibromas.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023284
- 003
- CZ-PrNML
- 005
- 20201214125643.0
- 007
- ta
- 008
- 201125s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/PGP.0000000000000573 $2 doi
- 035 __
- $a (PubMed)30575604
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a McCluggage, W Glenn $u Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK (W.G.M.) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital Hradec Kralove, Czech Republic (H.V., J.L.).
- 245 10
- $a Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma / $c WG. McCluggage, H. Vosmikova, J. Laco,
- 520 9_
- $a Mesonephric-like adenocarcinomas are rare neoplasms occurring in the uterine corpus and ovary which bear a close morphologic resemblance to cervical mesonephric adenocarcinomas. They also have a similar immunophenotype and harbor similar molecular abnormalities to mesonephric adenocarcinomas and it is debated whether they are truly of mesonephric origin or represent Mullerian neoplasms closely mimicking mesonephric adenocarcinomas. We report an unusual case with bilateral ovarian serous borderline tumors and extraovarian low-grade serous carcinoma (invasive implants). In one ovary, there was a component of mesonephric-like adenocarcinoma. The immunophenotypes of the serous and the mesonephric-like components were distinct and as expected for the individual tumor types (serous component diffusely positive with WT1 and estrogen receptor and negative with GATA3, TTF1 and CD10; mesonephric-like component WT1 and estrogen receptor negative and GATA3, TTF1, and CD10 positive; both components diffusely positive with PAX8 and exhibiting "wild-type" p53 immunoreactivity). In all components (bilateral serous borderline tumors, low-grade serous carcinoma and mesonephric-like adenocarcinoma), an identical KRAS mutation was detected (NM_004985.4): c.35G>A, p.(G12D) proving a clonal association between the serous and mesonephric-like components and excluding a collision neoplasm. This represents the second reported case of a combined ovarian low-grade serous tumor and mesonephric-like adenocarcinoma; in the previously reported case, an identical NRAS mutation was present in both components. These 2 cases provide evidence that ovarian mesonephric-like adenocarcinomas have, at least in some cases, a Mullerian origin and differentiate along mesonephric lines. We present additional evidence for this by reviewing associated findings in published and unpublished ovarian mesonephric-like adenocarcinomas; 8 of 11 of these neoplasms contained other Mullerian lesions in the same ovary, mainly endometriosis and adenomas/adenofibromas.
- 650 _2
- $a adenokarcinom $x diagnostické zobrazování $x genetika $x patologie $7 D000230
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a serózní cystadenokarcinom $x diagnostické zobrazování $x genetika $x patologie $7 D018284
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a ductus Mülleri $x patologie $7 D009095
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a nádory vaječníků $x diagnostické zobrazování $x genetika $x patologie $7 D010051
- 650 _2
- $a protoonkogenní proteiny p21(ras) $x genetika $7 D016283
- 650 _2
- $a ultrasonografie $7 D014463
- 650 _2
- $a vagina $x diagnostické zobrazování $7 D014621
- 650 _2
- $a Wolffovy vývody $x patologie $7 D014928
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vosmikova, Hana
- 700 1_
- $a Laco, Jan
- 773 0_
- $w MED00002324 $t International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists $x 1538-7151 $g Roč. 39, č. 1 (2020), s. 84-92
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30575604 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214125642 $b ABA008
- 999 __
- $a ok $b bmc $g 1595603 $s 1113960
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 39 $c 1 $d 84-92 $e - $i 1538-7151 $m International journal of gynecological pathology $n Int J Gynecol Pathol $x MED00002324
- LZP __
- $a Pubmed-20201125